title: [Treatment of primary urethral carcinoma. Guidelines from the French Urological Association. Cancer committee].
abstract: The litterature dealing with the treatment of primary uretral carcinoma is very limited. Most of it is based on small series, case report or expert opinions. These guidelines are level IV. The treatment modality is mainly based on the lesion topography and not on the histology. For anterior T1 or 2 lesions, surgery is the most often used modality. In women, radiotherapy might be an attractive option. For more advanced lesions, the combination of radiotherapy and chemotherapy is the standard of care. The optimal protocol remains to be defined. Intradiverticular lesions in women are mainly adenocarcimoma. Surgery only is often inadequate.
authors.affiliation: Polyclinique Saint-Roch, Montpellier, France.
authors.forename: F
authors.initials: F
authors.lastname: Iborra
authors.forename: J
authors.initials: J
authors.lastname: Rigaud
authors.forename: C
authors.initials: C
authors.lastname: Bastide
authors.forename: N
authors.initials: N
authors.lastname: Mottet
mesh_terms: D001500:BCG Vaccine / Q000627:therapeutic use; D001918:Brachytherapy; D002277:Carcinoma / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D005602:France; D006801:Humans; D018714:Radiotherapy, Adjuvant; D014523:Urethral Neoplasms / Q000628:therapy*
chemical_list: D001500:BCG Vaccine